Skip to main content
. 2006 Jan;77(1):12–17. doi: 10.1136/jnnp.2005.069161

Table 3 Literature review of complications of DBS STN implantation*.

Authors and year No. of patients (electrodes) Minimum no. of months of follow up Mortality (% of patients) and cause ICH (% of leads) Infection or erosion (% of leads) Other serious complication (% of patients) Confusion (% of patients)
Kumar et al., 1998 22 (44) 12 0 (0) 1 (2.3) NR 1 lead migration (4.5) 7 (31.8)
Limousin et al., 1998 24 (48) 12 0 (0) 1 (2.1); persistent aphasia/severe paralysis 1 (2.1) NR 8 (33.3)
Benabid et al., 2000 127 (253) NR 1 (0.8); PE 5 (2.0); 2 symptomatic, 3 asymptomatic “Less than 5%” 4 transient hemiballism (3.1) 7 (5.5)
Houeto et al., 2000 23 (46) 6 0 (0) 0 (0) 0 (0) 0 (0) 3 (13.0)
Rodriguez‐Oroz et al., 2000 15 (30) 12 0 (0) 2 (6.7); permanent motor deficits NR 1 wound haematoma requiring drainage (6.7) 1 (6.7)
Beric et al., 2001 61 (122) NR 0 (0) NR NR NR 4 (6.6)
Broggi et al., 2001 17 (34) 6 0 (0) 1 (2.9); silent NR NR 3 (17.6)
DBS for PD Group, 2001 102 (198) 6 0 (0) 3 (1.5) 4 (2.5) 3 seizures (2.9), 1 PE (0.9), 1 brachial plexus injury (0.9), 1 nonhaemorhagic paralysis (0.9), 3 lead migrations (2.9), 1 lead break (0.9) 1 (1.0)
Lopiano et al., 2001 20 (40) NR 0 (0) NR 1 (2.5) NR 2 (10.0)
Ostergaard et al., 2002 26 (52) 12 0 (0) NR 1 (1.9) 1 seizure (3.8) 3 (11.5)
Simuni et al., 2002 13 (26) 12 1 (7.7); PE 1 (3.8); transient 2 (7.7) 1 seizure (7.7), 1 subdural haematoma (7.7%) 1 (7.7)
Starr et al., 2002 44 (76) NR 0 (0) 2 (2.6) 2 (2.6) 2 seizures (4.5), 1 lead break (2.3) 9 (20.5)
Tavella et al., 2002 47 (94) 3 0 (0) NR 1 (1.1) NR 7 (14.9)
Vesper et al., 2002 38 (76) 12 0 (0) NR 2 (2.6) NR 10 (26.3)
Herzog et al., 2003 48 (96) 6 0 (0) 1 (1.0); transient NR 1 dislocation of impulse generator (2.1), 1 subdural haematoma (2.1) 7 (14.6)
Krack et al., 2003 49 (98) 3 (5 years in 42) 1 (2.0); ICH 10 (10.2); 2 permanent, 8 asymptomatic 5 (5.0) 2 seizures (4.1), 2 contusions (4.1), 1 ballism (2.0), 1 depressive suicide (2.0), 1 heart failure (2.0) 12 (24.5)
Landi et al., 2003 72 (144) 6 0 (0) 1 (0.7); transient 4 (2.8) 1 PE (1.4) 8 (11.1)
Pahwa et al., 2003 35 (70 12 0 (0) 0 (0) 5 (7.1) 1 fracture (2.9), 3 seizures (8.6), 5 (14.3)
Tamma et al., 2003 30 (60) 12 0 (0) NR NR 3 contusions (10.0) 9 (30.0)
Present study 100 (191) 6 0 (0) 1 (0.5); transient 9 (4.7) 3 seizures (3.0), 2 wound haematomas requiring drainage (2.0), 1 subdural haematoma (1.0), 1 extension wire replacement (1.0) 13 (13.0)

*NR, Not reported; ICH, intracerebral haemorrhage; PE, pulmonary embolism. Mortality rate 3/913 (0.3%); symptomatic ICH 17/1796(0.9%). Total incidence of confusion (patients) 120/913 (13.1%) (without DBS 119/811 (14.7%)) (range 5.5 to 33.3%). Total incidence of reported infection/erosion (leads) 36/1157 (3.1%) (range 0 to 7.7%)